Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
Go back to Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®| (NASDAQ: ORGO) | Delayed: 1.86 -0.05 (2.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.91 | 52 Week High | $ | |||
| Open | $1.88 | 52 Week Low | $ | |||
| Day High | $1.92 | P/E | N/A | |||
| Day Low | $1.86 | EPS | $ | |||
| Volume | 350,142 | |||||

